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Abstract A clinical trial simulation of Boron Neutron Capture Therapy (BNCT) for breast cancer was conducted 
at National Nuclear Energy Agency Yogyakarta, Indonesia. This was motivated by high rate of breast cancer in the 
world, especially in Indonesia. BNCT is a type of therapy by nuclear reaction 10B(n,α)7Li that produces kinetic energy 
totaling 2.79 MeV. High Linear Energy Transfer (LET) radiation of α-particle and recoil 7Li would locally deposit 
their energy in a range of 5-9 μm, which corresponds to the human cell diameter. Fast neutron coming out of Compact 
Neutron Generator (CNG) was moderated using Fe and MgF
2
 material. A collimator, along with breast cancer and the 
corresponding organ at risk were designed compatible to Monte Carlo N-Particle X (MCNPX). The radiation were 
simulated by the MCNPX software and the physical quantities were counted by tally MCNPX codes. The highest neutron 
thermal flux was found at a depth of 1.4 cm on fat tissue. En face and upward intersection radiation techniques were 
adopted for the breast cancer radiation. The average dose rate of radiation used on breast cancer was 1.72×10-5 Gy/s 
for the en face method and 8.98×10-6 Gy/s for the upward intersection method. Dose 50±3 Gy was given into cancer 
cell, (4.18±0.06) ×10-2 Gy into heart and (8.16±0.06) ×10-2 Gy into lung for 806.34 hours irradiation.
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INTRODUCTION
BNCT has been regarded as a potential 
method for cancer treatment (Anonim C, 2001; 
Jenkins, 2012; Andoh et al., 2014; Capoulat 
el al., 2014; Aihara et al., 2014). The neutron 
capture therapy concept was implemented 
for the first time after Chadwick neutron 
invention in 1932, followed by cross-section 
invention between 10B and thermal neutron 
by Golhaber in 1934 (Anonim C, 2001). 
Golhaber showed that thermal neutron reacts 
with10B  producing7Li, alpha particle, and 
gamma radiation. This invention became the 
foundation for BNCT.
Boron Neutron Capture Therapy (BNCT) 
is a radiotherapy that utilizes 10B(n,α)7Li  nuclear 
reaction resulting High Linear Energy Transfer 
(LET) of α-particle and recoil 7Li to destruct 
cancer cells. The reaction cross-section between 
Boron-10 and thermal neutron is ~3837 barn. 
The reaction between Boron-10 and thermal 
neutron is shown as:
 
 
   
where the α-particle LET is ~150 keV/μm 
and the7Li LET is ~175 keV/μm. These heavy 
particles locally deposit their energy in a range 
of 5-10 μm, which corresponds to the human 
cell diameter (Shaaban et al., 2015). BNCT is 
a promising method for selective cancer cells 
destruction.
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MATERIALS AND METHODS
This research consists of three parts: 
collimator design; breast cancer and organ at 
risk modeling; and radiation dose calculating. 
The simulation method used in this work is a 
Monte Carlo method, implemented using the 
MCNPX software by Los Alamos National 
Laboratory. Visual editor 5-4.23-12N software 
is used to visualize the collimator design and 
breast cancer model.
The collimator design is made taking 
into account the shape of the neutron source. 
Materials with high inelastic scattering cross-
section are chosen as moderator. Material 
with high scattering cross-section and low 
absorption cross-section is chosen as reflector. 
Material with high thermal neutron absorption 
is chosen as thermal neutron filter. Material with 
high gamma absorption is chosen as gamma 
absorption. Then, all the chosen materials are 
designed into a collimator. The IAEA criteria are 
the standard for the collimator output. The IAEA 
criteria for collimator are shown in Table 1.The 
breast cancer and organ at risk are designed 
based on cross-section view from computed 
At first, BNCT was applied for high-grade 
brain cancer such as glioblastoma. However, 
along with the development of research, some 
researchers have investigated application of BNCT 
for breast cancer treatment. Some researches has 
been conducted to produce a breast cancer therapy 
protocol based on BNCT. Some of the researches 
related to breast cancer treatment are radiation 
dose evaluation (Yanagie et al., 2009; Loong et 
al., 2014), optimal radiation technique (Horiguchi 
et al., 2011) and a feasibility study evaluating 
BNCT for potential role (Jenkins, 2012). If the 
boron atoms accumulate in the cancer cells, then 
inflammatory breast cancer is easily invaded 
(Yanagie, 2012).
D-D coaxial Compact Neutron Generator 
(CNG) is a safe neutron source because it does 
not use radioactive material, so that it is widely 
available in the market. D-D coaxial CNG 
generates neutron strength of ~1012 n/s. D-D 
reaction that generates neutron is expressed as:
with  and .
Table 1. IAEA criteria for output collimator
Design
Source 
strength 
(n/s)
 (n.cm-
2.s-1)
 (Gy.
cm2.n-1)
 (Gy.
cm2.n-1)
IAEA - >1,0× 109 < 2,0 × 10-13 < 2,0 × 10-13 > 100 > 20 > 0,7
Figure 1.  The CT cross section view imaging 
(Alanyah et al., 2013)
Figure 2.  The ORNL phantom cross section view  
(Krstic et al., 2014)
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tomography imaging and ORNL phantom. The 
tomography imaging and ORNL phantom cross-
section views are shown in Fig.1 and Fig.2, 
respectively. Finally, physical quantities needed 
for radiation dose calculation are counted by 
MCNPX tally. Dose calculating is conducted for 
two techniques, en face and upward intersection 
radiation techniques.
The BNCT doses calculations made are 
as follows:
The neutron scattering involves thermal 1. 
neutron, epithermal neutron, and fast 
neutron scatterings obtained from MCNPX 
computation. The scattering doses are 
obtained using the tally code “DE” and 
converted to Gy/s unit using the tally code 
“DF”.
Recoil proton dose is obtained from thermal 2. 
neutron reaction with nitrogen-14 with 
reaction equation: 
The amount of energy released in this 
reaction is 0.66 MeV.
Photon dose consists of:3. 
photon dose from the collimator (obtained a. 
from MCNPX computation)
photon dose from the reaction of thermal b. 
neutron with hydrogen with reaction 
equation:
 The amount of photon energy released 
from this reaction is 2.23 MeV.
photon dose from the reaction of thermal c. 
neutron with boron is 0.48 MeV, with 
reaction probability of 93.9% (this 
reaction is involved in the boron dose 
mentioned in no. 4 below).
Boron dose is obtained from the reaction of 4. 
boron with neutron with reaction equation:
 there are two kinds of reaction of boron-
10 with neutron. First, with probability 
of 93.9%, it results in alpha particle (1.47 
MeV), lithium (0.84 MeV), and photon 
(0.48 MeV). Second, with probability of 
6.1%, it results in alpha particle (1.01 MeV) 
and lithium (1.78 MeV). So, an average 
energy amount of 2.33 MeV is involved in 
resulting alpha particle and lithium.
The BNCT total dose is formulated as:
          (1)
 (boron dose),  (photon dose),  (neutron 
scattering dose),  (recoil proton dose) are 
calculated using the following formulas:
 ; +             (2)
where  (flux),  (photon induction 
from collimator),and D
n
 (neutron scattering 
energy) are obtained using MCNPX. The 
values  are thermal neutron cross-sections of 
the corresponding atoms ,  is the number of 
particles of the corresponding atom  and  is 
the energy resulting from reaction between the 
particles with thermal neutron,  is the fraction 
of gamma energy deposited at the local site, and 
 is the gamma energy of thermal reactions of 
boron and thermal neutron with nitrogen.
RESULTS AND DISCUSSION
Collimator design
Reflector
The materials tested as reflector are 64Ni, 
206Pb, 209Bi, BeO and PbF
2
 as IAEA recommends. 
The neutron current output on a fixed aperture is 
shown in Fig.3. Based on Fig.3, BeO and 209Bi 
produce high amount of thermal neutron, which 
is not desirable. So, PbF
2
 and 64Ni are chosen as 
the best materials for the reflector. Further, the 
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best one is chosen by calculating neutron flux 
at different thicknesses of the materials. The 
result is given in Fig.4.
The highest neutron flux is given by PbF
2
. 
Therefore, PbF
2 
is chosen as the material of the 
reflector in this research. 
Moderator
The materials tested as moderator are 56Fe, 
27Al, AlF
3
, LiF, Al
2
O
3
, MgF
2
 and TiF
3
 as IAEA 
recommends. Fast neutron (2.5 MeV) needs to 
be moderated to epithermal neutron level (0.025 
eV < E < 10 keV).Most materials have inelastic 
scattering cross-section starting at energy ≥100 
keV, but Iodine atom has inelastic scattering 
cross-section starting at lower neutron energy 
(< 50 keV). AlI
3
is used as part of the moderator 
in this research. D-D Coaxial Compact Neutron 
Generator produce low neutron source strength, 
~1012 n/s at radius 14 cm. So, the collimator has 
to be short to obtain higher neutron flux. The 
result obtained at the fixed aperture for some 
physical quantities is shown in Table 2 and the 
collimator design based on Table 2 is shown in 
Fig. 5. Thermal neutron filter and gamma filter 
use6Li and 209Bi, respectively. Intermittent material 
design is used to absorb thermal neutron, so that 
low thermal neutron flux is obtained.
The collimator output from the proposed 
collimator design and other Beam 
Breast cancer and organ at risk modeling
Breast cancer and organ at risk are modeled 
based on Fig.1 and Fig.2.  The model is shown 
in Fig.6. The breast cancer and organ at risk 
shapes are limited by MCNPX capability. So, 
the made-up model was a simple model.
Radiation techniques
There are two radiation techniques used, en 
face radiation technique and upward intersection 
radiation technique, as shown in Fig. 7.
Radiation Dosimetry
Thermal neutron flux
Thermal neutron flux at various depths 
are measured to determine maximum thermal 
neutron flux depth, as shown in Fig. 8. Best 
Figure 3.  Neutron current reflector materials 
calculated on a fixed aperture
Figure 4.  Neutron flux reflector materials calculated 
on a fixed aperture
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Table 2. Collimator aperture outcome using different moderator, thermal neutron filter and gamma filter materials
Design
(materials arranged sequentially)
Source 
strength
(n/s) (n.cm
-2.s-1) (Gy.cm2.n-1) (Gy.cm2.n-1)
IAEA >1.0× 109 < 2.0 × 10-13
< 2.0 × 
10-13
> 100 > 20 > 0.7
Al (69.8 cm)
2.0× 1012
5.0 × 107 3.8 × 10-25 1.4 × 10-26 64.2 2.8 71.7
Fe(69.8 cm) 3.2 × 106 2.6 × 10-25 1.2 × 10-26 167.2 0.8 62.9
AlF
3
(69.8 cm) 1.5 × 107 8.4 × 10-25 2.8 × 10-26 6.1 29.4 72.1
Al
2
O
3
(69.8 cm) 9.6 × 106 2.1 × 10-25 1.4 × 10-24 4.1 2.0 68.8
LiF(69.8 cm) 7.0 × 105 7.2 × 10-26 7.9 × 10-27 - 9.5 69.1
Fluental(69.8 cm) 2.0 × 107 5.0 × 10-26 1.7 × 10-26 39.7 18.1 71.5
MgF
2
(69.8 cm) 8.6 × 106 1.7 × 10-26 4.6 × 10-26 2.3 85.2 71.2
TiF
3
(69.8 cm) 6.91× 106 2.8 × 10-26 2.6 × 10-25 30.8 72.1 72.2
Fe (10.8 cm)+MgF
2
(59 cm) 9.1 × 106 1.5 × 10-26 4.6 × 10-27 3.2 67.3 69.1
Fe (10.8cm)+MgF
2
(62cm)+Bi 
(1cm)+MgF
2 
(0.1cm)+Bi (0.9cm)
7.1 × 106 1.6 × 10-26 2.1 × 10-26 3.14 63 69.6
Fe(10.8cm)+MgF
2
(10cm)+6Li(1cm) 
MgF
2
(4cm)+IF
3
(1cm)+MgF
2
(43cm)+6Li(0.2cm)+MgF
2
(2
.4cm) +6Li(0.2cm)+Bi(1cm) 
+6Li(0.1cm)+Bi(0.9cm)  
2.1 × 106 6.7 × 10-26 3.2 × 10-26 230 21 71.4
Table 3. Comparison between this proposed design and some published works
Design
Source 
strength
(n/s) (n.cm
-2.s-1) (Gy.cm2.n-1) (Gy.cm2.n-1)
IAEA - >1.0× 109 < 2.0 × 10-13 < 2.0 × 10-13 > 100 > 20 > 0.7
Fantidis et al., 2013 1011 1.17x106 1.11x10-17 2.32x10-17 128.81 20.81 -
Durisi et al., 1011 1.8x106 1,82x10-12 2.98 x10-13 - - -
This proposed 
collimator design
1012 2.1 × 106 6.7 × 10-26 3.2 × 10-26 230 21 71.4
Figure 5.  Proposed collimator design 
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Figure 6.a.  Breast cancer and organ at risk 3D 
Vised visualization, cross-section view
Figure 7.a.  En face radiation technique Figure 7.b. Upward intersection radiation technique
Figure 8.  Thermal neutron flux versus depth Figure 9.  Radiation dose at cancer cell and organ at risk
Figure 6.b.  Breast cancer and organ at risk 3D 
Vised visualization, en face view
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radiation technique will be determined by 
maximum thermal neutron depth. Neutron flux 
is calculated by MCNPX tally for en face and 
upward intersection radiation techniques, then 
dose radiation is calculated. The dose radiation 
comparison between the two techniques is given 
in Fig.9.
Exposure time
Exposure time is calculated based on 
maximum dose at healthy tissue 12.5 Gy/s, 
maximum dose at skin 8 Gy/s and minimum 
dose to destruct breast cancer~50 Gy/s. Exposure 
time calculation based on the three criteria is 
shown in Fig. 10.
Based on exposure time calculated on 
diagram, 806.34 hours is the acceptable 
exposure time. This result is chosen for skin 
and healthy tissues exposure safety. But, 806.34 
hours irradiated produce 50 ± 3 Gy on breast 
cancer cell, (4.18±0.06) ×10-2 Gy on heart and 
(8.16±0.06) ×10-2 Gy on lung.
CONCLUSION AND REMARKS
 The low radiation dose on cancer cells 
shows that the result obtained in this research 
is still inadequate. The main factor resulting in 
the low dose is a low amount of neutron source 
strength. To obtain high neutron flux, neutron 
source with high source strength is needed. 
Other efforts to optimize the result are trying 
varying radiation techniques and optimizing 
the collimator design.
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